Izokibep - Affibody
Alternative Names: ABY 035; ABY-035/AFO2; AFB-035; IMG-020; IMG-20Latest Information Update: 02 Jun 2025
At a glance
- Originator Affibody
- Developer ACELYRIN; Affibody; Alumis
- Class Anti-inflammatories; Antipsoriatics; Antirheumatics; Recombinant fusion proteins
- Mechanism of Action IL17A protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Ankylosing spondylitis; Axial spondyloarthritis; Hidradenitis suppurativa; Plaque psoriasis; Psoriasis; Psoriatic arthritis; Uveitis